©The Author(s) 2016.
World J Gastroenterol. Feb 7, 2016; 22(5): 1859-1868
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1859
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1859
Table 6 Correlation between clinicopathologic features determined by clinical staging and peritoneal metastasis or positive cytology (multivariate analysis)
| Variables | P value | Odd ratio | 95%CI |
| Tumor size (mm) | |||
| < 40 | 1.000 | ||
| ≥ 40 | 0.015 | 2.123 | 1.160-3.887 |
| fT stage | < 0.001 | ||
| T2/3 | 1.000 | ||
| T4a | 0.215 | 1.714 | 0.731-4.020 |
| T4b | < 0.001 | 11.54 | 4.942-26.947 |
| Borrmann type | < 0.001 | ||
| Type I or II | 1.000 | ||
| Type III | < 0.001 | 6.291 | 3.524-11.231 |
| Type IV | < 0.001 | 5.844 | 2.457-13.904 |
- Citation: Hu YF, Deng ZW, Liu H, Mou TY, Chen T, Lu X, Wang D, Yu J, Li GX. Staging laparoscopy improves treatment decision-making for advanced gastric cancer. World J Gastroenterol 2016; 22(5): 1859-1868
- URL: https://www.wjgnet.com/1007-9327/full/v22/i5/1859.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i5.1859